EQUINEXT
Equinext, LLC develops technologies for the treatment of ligament and tendon injuries in horses in the United States. It offers nonsurgical exogenous crosslink therapy (NEXT), a chemically made device formed following injection of a crosslinking agent into the lesion of the tendon or ligament that interacts with the native proteins (collagen). The companyโs products are also used to treat the causes of wobblerโs disease and intervertebral disc degradation. It has strategic partnership with Hagyard Equine Medical Institute. The company was incorporated in 2011 and is based in Lexington, Kentucky.
EQUINEXT
Industry:
Hardware
Founded:
2011-01-01
Address:
Lexington, Kentucky, United States
Country:
United States
Website Url:
http://www.equinext.net
Total Employee:
1+
Status:
Closed
Contact:
866.348.1991
Email Addresses:
[email protected]
Total Funding:
985 K USD
Technology used in webpage:
SPF Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator
Current Employees Featured

Founder
Investors List
Keyhorse Capital (KSTC)
Keyhorse Capital (KSTC) investment in Seed Round - Equinext
Official Site Inspections
http://www.equinext.net
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Equinext"
Equinext - Crunchbase Company Profile & Funding
Equinext, LLC develops technologies for the treatment of ligament and tendon injuries in horses in the United States. It offers nonsurgical exogenous crosslink therapy (NEXT), a chemically โฆSee details»
Solutions โ You Can Count On
Equinext is your trusted partner in the pharmaceutical realm. Leveraging decades of expertise, we provide bespoke, end-to-end solutions that seamlessly align with your objectives. With a focus โฆSee details»
Equinext - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... Dec 4, 2013: Seed Round - Equinext โ obfuscated. obfuscated โ Dec 1, 2011: โฆSee details»
Equinext - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Equinext . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 2. About. Equinext has 2 current employee โฆSee details»
Equinext - Products, Competitors, Financials, Employees, โฆ
Headquarters Location. 1501 Bull Lea Road Suite 103. Lexington, Kentucky, 40511, United States. 866-348-1991See details»
Equinext - AboutUs
To develop, manu-facture, and sell an injectable reagent for the treatment of equine ligament, tendon tissue damage (lesions), and stifle joint injury occurring in all breeds of working and โฆSee details»
Equinext Careers, Perks + Culture - Built In
Equinext. Save Saved. Lexington, Kentucky, USA. 49 Total Employees. View Website. Jobs at Similar Companies. Voltage Park Technical Operations Manager. Dallas-Fort Worth, TX. โฆSee details»
Equinext Research & Development Foundation - The Company โฆ
Equinext Research & Development Foundation, headquartered in Delhi, New Delhi since its establishment in 2021, operates in the Non-Profit Organizations sector. Get insights on โฆSee details»
About Us โ EquiNext Research & Development โฆ
EquiNext/eqnโข was conceived by its founder in 2015 (around the same time when the world leaders were discussing the Paris Agreement!) and after an exceedingly long gestation period of almost 6 years, it saw the light of the day โฆSee details»
Equinext SA Company Profile | Genève, GENÈVE, Switzerland
Find company research, competitor information, contact details & financial data for Equinext SA of Genève, GENÈVE. Get the latest business insights from Dun & Bradstreet.See details»
Equinext - Updates, News, Events, Signals & Triggers - Crunchbase
Dec 1, 2011 Equinext LLC develops technologies for the treatment of ligament and tendon injuries in horses. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. โฆSee details»
Anupama Chittaranjan - EquiNext Research & Development โฆ
An exceptional motivator and strategic planner who believes that change is the only constant, she started EquiNext Research and Development Foundation, a non-profit organization in the year โฆSee details»
Anupama Chittaranjan - Founding Director - EquiNext Research ...
Founding Director at EquiNext Research & Development Foundation · CONSCIOUS LEADERSHIP PRACTITIONER | CLIMATE ACTION CHAMPION | SOCIAL IMPACT MAKER โฆSee details»
CAREER - equinextsolution.com
At Equinext, we seamlessly merge international insights with profound local understanding, carving out cutting-edge solutions for the pharmaceutical and nutraceutical sectors. As we โฆSee details»
EQUINEXT SOLUTION - LinkedIn
Equinext intends to deliver turnkey pharmaceutical solutions market by implementing Industry 4.0 technologies, such as automation, robotics, and artificial intelligence, and their significant ...See details»
Equinext Solution Overview | SignalHire Company Profile
Equinext is your trusted partner in the pharmaceutical realm. Leveraging decades of expertise, we provide bespoke, end-to-end solutions that seamlessly align with your objectives. ...See details»
Equinext - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Equinext uses 6 technology products and services including HTML5, Wordpress, and Modernizr, according to G2 Stack. Equinext is actively using 5 technologies for its website, according to โฆSee details»
EQUINEXT RESEARCH & DEVELOPMENT FOUNDATION - Zauba โฆ
Organization * Designation * Username * E-mail address * A valid e-mail address. All e-mails from the system will be sent to this address. ... Equinext Research & Development Foundation is a โฆSee details»
eqnโข- We are working on Advocacy,Research & Capacity building
EquiNext Research & Development Foundation / eqnโข is committed to global research, advocacy, and capacity-building that identifies and promotes holistic solutions to โฆSee details»
Eric Hauck - Chairman & CEO @ Equinext - Crunchbase
Eric Hauck, president, CEO and co-founder, has extensive success bringing disruptive technologies to market. He has 27 years of experience as a CEO and president with various โฆSee details»